Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Learn About This Non-Invasive Clinical Trial for Alzheimer's Disease

  • Broadcast in Caregiving
Alzheimers Speaks Radio

Alzheimers Speaks Radio


Follow This Show

If you liked this show, you should follow Alzheimers Speaks Radio.

                  Today’s show is live and as always you are invited to call in and ask your questions or make comments at 323-870-4602.

Lori La Bey will be talking with Leen Kawas, the President and Chief Executive Officer of Athira Pharma, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration.  Joining them will be Doctor Anton Porsteinsson, who is a Professor of Psychiatry, Neurology, Neuroscience, and Medicine at the University of Rochester School of Medicine and Dentistry in Rochester, New York.  He is also the Director of the University of Rochester’s Alzheimer’s Disease Care, Research and Education Program (AD-CARE).  Come join the conversation about this exciting trial.

Contact  Athira Clinical Trials:     Website       To discuss study participation: 1-800-668-4717 US or 1800-043-212 AUS

Contact Lori La Bey with questions or branding needs at Alzheimer’s Speaks  www.AlzheimersSpeaks.com

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled